NHI.no
Annonse
Informasjon

Høyt stoffskifte (hypertyreose)

Høyt stoffskifte er en sykdom som skyldes økt produksjon av hormoner som lages i skjoldkjertelen. Symptomene kan blant annet inkludere hjertebank, nervøsitet, tretthet, vekttap, svetting og stirrende blikk.

Høyt stoffskifte kan gi mange symptomer, men få utvikler alle.

Sist oppdatert:

7. feb. 2024

Vil du vite mer

Vil du vite mer - Kurs om stoffskiftesykdommer

Dette dokumentet er basert på det profesjonelle dokumentet Hypertyreose . Referanselisten for dette dokumentet vises nedenfor

  1. Koren-Dahll L, Nedrebø BG, Norheim I, et al. Graves' hypertyreose. Versjon 3.4. Nasjonal veileder i endokrinologi. Sist oppdatert 03.08.2022. metodebok.no
  2. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet 2016 Aug 27; 388(10047): 906–918. www.ncbi.nlm.nih.gov
  3. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142–54.
  4. Bjøro T, Holmen J, Krüger Ø, et al. Prevalens av hypotyreose og hypertyreose i Nord-Trøndelag. Tidsskr Nor Lægeforen 2002; 122: 1022-8. PubMed
  5. Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99:923–31. PMID: 24423323 PubMed
  6. Menconi F, Marcocci C, Marinò M. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 2014;13:398–402. PMID: 24424182 PubMed
  7. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Thyroid 2016; 26: 10. DOI: 10.1089/thy.2016.0229 DOI
  8. Schwartz F, Bergmann N, Zerahn B, Faber J. Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies. Scand J Clin Lab Invest. 2013;73:240–44. PMID: 23438331 PubMed
  9. Anfinsen O-G, Lima K. Amiodaronindusert tyreotoksikose. Tidsskr Nor Legeforen 2021. doi:10.4045/tidsskr.21.0047 DOI
  10. Kravets I. Hyperthyroidism: Diagnosis and Treatment. Am Fam Physician. 2016;93(5):363-370. PubMed
  11. Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis. BMJ. 2014;349:g5128. doi: 10.1136/bmj.g5128.
  12. Ross DS. Diagnosis of hyperthyroidism. UpToDate, last updated Oct 15, 2021. UpToDate
  13. Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011; 21: 593. PubMed
  14. Norsk kvalitetsforbedring av laboratorieundersøkelser (Noklus). Anbefalte analyser ved utvalgte kliniske problemstillinger. Siden besøkt 28.09.2020. www.noklus.no
  15. Babovic A, Müller C, Bach-Gansmo C. Når er det indikasjon for thyreoideascintigrafi?. Tidsskr Nor Legeforen 2013.
  16. Burch HB, Burmann KD, Cooper DS. A 2011 survey of clinical practice patterns in the management of Graves' disease. J Clin Endocrinol Metab 2012; 97: 4549. pmid:23043191 PubMed
  17. Abraham P, Avenell A, McGeoch SC, Clark LF, Bevan JS. Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD003420. DOI: 10.1002/14651858.CD003420.pub4 DOI
  18. Ross DS. Graves' hyperthyroidism in nonpregnant adults: Overview of treatment. UpToDate, last updated Jul 28, 2020. UpToDate
  19. Colaco SM, Si M, Reiff E, Clark OH. Hyperparathyroidism after radioactive iodine therapy. Am J Surg 2007; 194: 323-7. PubMed
  20. Okosieme OE, Taylor PN, Evans C, et al. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study. Lancet Diabetes Endocrinol 2019; 7: 278-287. pmid:30827829 PubMed
  21. Bogazzi F, Giovanetti C, Fessehatsion R, et al. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. J Clin Endocrinol Metab 2010; 95: 201-8. PubMed
Annonse
Annonse